Arun Nidhi, Choudhary Annu, Kumar Mukesh
Anaesthesiology, Indira Gandhi Institute of Medical Sciences, Patna, IND.
Surgery, Indira Gandhi Institute of Medical Sciences, Patna, IND.
Cureus. 2022 Jul 5;14(7):e26572. doi: 10.7759/cureus.26572. eCollection 2022 Jul.
Pre-operative anxiety in children not only makes induction difficult but it is also associated with an increase in the requirement of analgesics, the incidence of post-operative nausea and vomiting (PONV), emergence delirium (ED), and postoperative maladaptive behavioral changes. It can be reduced effectively by pharmacological interventions. In a quest to find the ideal premedicant and non-invasive way of its administration, we decided to compare intranasal (IN) dexmedetomidine with IN ketamine as a premedicant in pediatric patients.
To compare sedation score, mask acceptance score (MAS) during induction, the incidence of ED, and other adverse events in both groups.
Some 60 children, between 1 and 8 years of age of either sex undergoing surgical procedures were included in this study and randomly divided into two groups (Group D and Group K). Thirty minutes prior to induction of anesthesia, patients of Group D received dexmedetomidine 1 mcg kg in 1 mL of 0.9% saline intranasally and patients of Group K received ketamine 5 mg kg in 1 mL of 0.9% saline intranasally through calibrated dropper (0.5 mL in each nostril) in a recumbent position. Incidences of sneezing or coughing after IN administration of study drugs were recorded. The subsequent sedation scores were assessed using MOASS at 15 min, then at 30 min following premedication at the time of parental separation. After shifting patients to operation theater inhalation induction was done. MAS at induction and any adverse effects were recorded.
Children in Group K were found to be significantly more sedated at 30 min after administration of premedication and mask acceptance was also better (p value < 0.0001 with a confidence interval, CI=95%). But the incidence of ED and PONV was high.
Intranasal dexmedetomidine (1 mcg kg) is clinically less effective as a premedicant in terms of sedation and mask acceptance in older children as compared to ketamine (5 mg kg), but associated with fewer incidence of ED and PONV. We recommend the usage of IN dexmedetomidine in a higher dose (1.5-2 mcg kg), through nebulization/atomizer for the desired level of sedation and mask acceptance.
儿童术前焦虑不仅会使诱导过程变得困难,还与镇痛药需求量增加、术后恶心呕吐(PONV)发生率、苏醒期谵妄(ED)以及术后适应不良行为改变有关。药物干预可有效减轻这种焦虑。为了找到理想的术前用药及其非侵入性给药方式,我们决定比较鼻内给予右美托咪定与鼻内给予氯胺酮作为儿科患者术前用药的效果。
比较两组患者的镇静评分、诱导期间的面罩接受评分(MAS)、ED发生率及其他不良事件。
本研究纳入了约60名年龄在1至8岁、接受外科手术的儿童,随机分为两组(D组和K组)。麻醉诱导前30分钟,D组患者经校准滴管(每侧鼻孔0.5 mL)以鼻内给药方式给予1 μg/kg右美托咪定溶于1 mL 0.9%盐水中,K组患者以同样方式鼻内给予5 mg/kg氯胺酮溶于1 mL 0.9%盐水中,给药时患者为卧位。记录研究药物鼻内给药后打喷嚏或咳嗽的发生率。在用药后15分钟、用药后30分钟(即父母离开时)使用改良警觉/镇静评分(MOASS)评估随后的镇静评分。将患者转移至手术室后进行吸入诱导。记录诱导时的MAS及任何不良反应。
发现K组儿童在用药后30分钟时镇静程度明显更高,面罩接受情况也更好(p值<0.0001,置信区间CI = 95%)。但ED和PONV的发生率较高。
与氯胺酮(5 mg/kg)相比,鼻内给予右美托咪定(1 μg/kg)在大龄儿童中作为术前用药时,在镇静和面罩接受方面临床效果较差,但ED和PONV的发生率较低。我们建议通过雾化器/喷雾器以更高剂量(1.5 - 2 μg/kg)鼻内给予右美托咪定,以达到所需的镇静水平和面罩接受度。